DUBLIN--(BUSINESS WIRE)--May 4, 2021--

The "The Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs)" report has been added to ResearchAndMarkets.com's offering.

Contract manufacturing is an increasing part of the pharmaceutical business. In cell therapy, this need is magnified because of the demand for cell and gene therapy products.

The report the Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs) details the following:

  • Biopharmaceutical Contract Manufacturing Market
    • Role
    • Services Offered
    • Usage Drivers
  • Profiles of Companies, Key Players, and Competitors in the Market
  • COVID-19's Challenges and Opportunities for CMOs
  • Global and Regional Market Overviews - U.S., Europe, and Other Nations
  • New Developments and Advancing Technology
    • Development pipeline
    • Production Issues
    • Cost
    • Logistics
  • Mergers and Acquisitions

There are many companies in this market, and the analyst profiles a select group of companies that are representative of the market or handle a large volume.

These companies include:

  • AGC Biologics
  • Ajinomoto Bio-Pharma Services
  • Anemocyte
  • Astellas
  • BioNTech IMFS
  • Boehringer Ingelheim BioXcellence
  • Bristol Myers Squibb
  • Catalent
  • Cognate BioServices/CRL
  • Cytiva
  • Cytovance Biologics
  • Fresenius Kabi Product Partnering
  • FUJIFILM Cellular Dynamics
  • FUJIFILM Diosynth Biotechnologies
  • Grifols
  • Lonza
  • Millipore Sigma/BioReliance
  • Minaris Regenerative Medicine
  • Novartis
  • Oxford Biomedica
  • Patheon/Thermo Fisher Scientific
  • Pfizer CentreOne
  • Porton Biologics
  • Syngene International
  • Takara Bio
  • Takeda
  • The Center for Breakthrough Medicines
  • Vibalogics
  • WuXi AppTec
  • WuXi Biologics
  • Yposkesi

Key Topics Covered:

Chapter 1: Executive Summary

Overview

Scope and Methodology

Covid 19

Market Overview and Potential

  • Cell and Gene Therapy Market
  • BCMO Market
  • Cell and Gene Therapy BCMO Market

Chapter 2: Introduction to Cell and Gene Therapy

Introduction

  • Cell Therapy
  • Gene Therapy
  • Viral Vector System and New Developments
  • Non-viral Systems for Transporting Genes
  • End Users
  • Hospitals
  • Research Institutes
  • Wound Care Centers
  • Cancer Centers

Chapter 3: Cell and Gene Therapy Industry - Product Pipeline, Production & Key Players

Overview

  • Regulatory Pathway
  • Priority Review
  • Accelerated Approval
  • Fast Track
  • Breakthrough Therapy
  • Orphan Drug
  • Individualized Gene Therapy Approval Process
  • Development Pipeline
  • Production Issues
  • Manufacturing Process for CAR-T
  • Advancements and Barriers in Manufacturing Processes
    • Cost
    • Timing
    • Logistics
    • Capacity Shortfall
    • In-House Manufacturing
    • Staffing
  • Key Players
  • Mergers and Acquisitions

Chapter 4: Cell and Gene Therapy Markets

Overview

  • Global Cell and Gene Therapy Markets
  • Regional Market Overview
  • United States
  • Europe/European Union
  • Other Countries
  • Leading Competitors

Chapter 5: Biopharma Contract Manufacturing

Introduction

  • The Role of BCMOs
  • Services Offered by BCMOs
  • Usage Drivers
  • Growth Constraints

Chapter 6: Biopharma Contract Manufacturing Markets

Overview

  • Global BCMO Markets
  • Regional Market Overview
  • United States
  • Europe/European Union
  • Other Countries
  • Leading Competitors

Chapter 7: Cell & Gene Therapy Contract Manufacturing

Introduction

  • Advancing Technology
  • Dearth of Intellectual Capital
  • cGMP Compliance
  • Quality by Design

Chapter 8: The Market for Cell & Gene Therapy Contract Manufacturing

Overview

  • Global Cell and Gene Therapy BCMO Market
  • Market by Therapeutic Indication
  • Market by Method
  • Market by Manufacturing Stage
  • Market by Global Region
  • Leading Competitors
  • Mergers and Acquisitions

Chapter 9: Key Players in the Cell & Gene Therapy CMO Market

For more information about this report visit https://www.researchandmarkets.com/r/hx4pfp

View source version on businesswire.com:https://www.businesswire.com/news/home/20210504005939/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: GENERAL HEALTH GENETICS HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2021.

PUB: 05/04/2021 10:31 AM/DISC: 05/04/2021 10:31 AM

http://www.businesswire.com/news/home/20210504005939/en

Copyright Business Wire 2021.

Recommended for you

(0) comments

Welcome to the discussion.

Real Names required. No pseudonyms or partial names allowed. Stand behind what you post.
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.

Thank you for reading!

Please log in, or sign up for a new account and purchase a subscription to read or post comments.